Continuous manufacturing is revolutionizing the pharmaceutical industry, offering a smarter, more efficient way to produce medications. This approach promises to streamline drug production processes, significantly enhancing efficiency, sustainability, and quality. However, the transition from
Have you ever wondered how strategic acquisitions can reshape an entire industry? In the ever-evolving biotech sector, where innovation and agility define success, companies continuously seek partnerships that promise transformative growth. Agilent Technologies' acquisition of Biovectra has
In the bustling realm of the pharmaceutical and biotechnology industries, few stories are as captivating as that of Lifecore Biomedical's ambitious journey to capitalize on CDMO market growth. As the global landscape shifts toward outsourcing and an increasing demand for U.S.-based production,
Across the rapidly evolving landscape of biotechnology, rare collaborations have the power to shift entire paradigms. In a surprising twist, Agenus, a U.S.-based biotech firm, and India's Zydus Lifesciences have entered an unexpected alliance. This partnership encompasses a significant transfer of
A powerful wave of growth is sweeping through the U.S. pharmaceutical manufacturing industry, driven by significant financial commitments from leading companies. In a landscape evolving with staggering demand, pharmaceutical giants like Johnson & Johnson and Eli Lilly are spearheading this
In the aftermath of the Trump administration, the pharmaceutical industry is left navigating a complex landscape shaped by initiatives aimed at fostering domestic manufacturing. Intended to bolster the United States’ pharmaceutical production capabilities, these policies introduced through
